• 中国精品科技期刊
  • 中国高校百佳科技期刊
  • 中国中文核心期刊
  • 中国科学引文数据库核心期刊
Advanced Search
XIANG Min, ZHANG Yaqin, WU Pingping, GAO Zhenyu. Effect of block of AGEs-RAGE pathway on the migration of VSMCs[J]. Journal of China Pharmaceutical University, 2016, 47(2): 199-203. DOI: 10.11665/j.issn.1000-5048.20160212
Citation: XIANG Min, ZHANG Yaqin, WU Pingping, GAO Zhenyu. Effect of block of AGEs-RAGE pathway on the migration of VSMCs[J]. Journal of China Pharmaceutical University, 2016, 47(2): 199-203. DOI: 10.11665/j.issn.1000-5048.20160212
shu

Effect of block of AGEs-RAGE pathway on the migration of VSMCs

More Information
    Graphical Abstract
    • Abstract
  • To investigate the effect of block of AGEs-RAGE pathway on the migration of aortic vascular smooth muscle in diabetic rats and its possible mechanisms, vascular smooth muscle cells(VSMCs)cells were pre-stimulated by antibody of RAGE, and then stimulated by AGEs. Transwell assay was adopted to assay migration of VSMCs. Proliferation of VSMCs and expression of p27 were analyzed by MTT and ELISA, respectively. The change of ROS level in VSMCs was defermined by DCFH assay, the expression of NOX1 mRNA was determined by RT-PCR assay. Results indicated that the AGEs induction for migration of VSMCs was significantly inhibited after treatment by RAGE antibody(P< 0. 01), which blocked the AGEs-RAGE pathway, and the inhibition of migration was stronger than that of proliferation. The ROS level was decreased(P< 0. 01), and the expression of NOX1 mRNA was decreased, yet the expression of P27 protein was not changed greatly. Block of AGEs-RAGE pathway by antibody of RAGE can inhibit the migration of VSMCs, and the mechanism may be related with the decrease of NOX1 mRNA and then down to the level of intracellular oxidative stress in VSMCs.
    • FullText(HTML)
    • References (14)
  • [1]
    Drummond GR,Selemidis S,Griendling KK,et al.Combating oxidative stress in vascular disease:NADPH oxidases as therapeutic targets[J].Nat Rev,2011,10:453-461.
    [2]
    Takac I,Schröder K,Brandes RP.The nox family of NADPH oxidases:friend or foe of the vascular system[J] ? Curr Hypertens Rep,2012,14(1):70-78.
    [3]
    Yamagishi S,Fukami K,Matsui T.Crosstalk between advanced glycation end products(AGEs)-receptor RAGE axis and dipeptidyl peptidase-4-incretin system in diabetic vascular complications[J].Cardiovasc Diabetol,2015,14(2):176-187.
    [4]
    Stirban A,Gawlowski T,Roden M.Vascular effects of advanced glycation endproducts:clinical effects and molecular mechanisms[J].Mol Metab,2013,3(2):94-108.
    [5]
    Li Y,Liu S,Zhang Z,et al.RAGE mediates accelerated diabetic vein graft atherosclerosis induced by combined mechanical stress and AGEs via synergistic ERK activation[J].PLoS One,2012,7(4):e35016.
    [6]
    Mei AH,Liu JX,Chen SF,et al.Insulin stimulates ROS production to promote VEGF expression,cells migration and proliferation of vascular smooth muscle cells[J].Chin J Pathophysiol(中国病理生理杂志),2013,29(2):272-277.
    [7]
    Cai Q,Li BY,Gao HQ,et al.Grape seed procyanidin b2 inhibits human aortic smooth muscle cell proliferation and migration induced by advanced glycation end products[J].Biosci Biotechnol Biochem,2011,75(9):1692-1697.
    [8]
    Reddy MA,Natarajan R.Epigenetic mechanisms in diabetic vascular complications[J].Cardiovasc Res,2011,90(3):421-429.
    [9]
    Fukami K,Yamagishi S,Okuda S.Role of AGEs-RAGE system in cardiovascular disease[J].Curr Pharm Des,2014,20(14):2395-2402.
    [10]
    Lü C,Liu HJ,Liu XL,et al.The research progress on RAGE and RAGE inhibitor[J].Chin Pharmacol Bull(中国药理学通报),2013,29(4):452-456.
    [11]
    Streeter J,Thiel W,Brieger K,et al.Opportunity Nox:the future of NADPH oxidases as therapeutic targets in cardiovascular disease[J].Cardiovasc Ther,2013,31(3):125-137.
    [12]
    Gray SP,Di Marco E,Okabe J,et al.NADPH oxidase 1 plays a key role in diabetes mellitus-accelerated atherosclerosis[J].Circulation,2013,127(18):1888-1902.
    [13]
    Kwon H,Lee JJ,Lee JH,et al.Cinnamon and its components suppress vascular smooth muscle cell proliferation by up-regulating cyclin-dependent kinase inhibitors[J].Am J Chin Med,2015,43(4):621-636.
    [14]
    Abhijit S,Bhaskaran R,Narayanasamy A,et al.Hyperglycemia-induced oxidative stress and its role in diabetes mellitus related cardiovascular diseases[J].Curr Pharm Des,2013,19(32):5695-5703.
    • Related Articles

  • Related Articles

    [1]LIU Li, ZHANG Qianwen, NONG Cheng, ZHANG Xi, XU Xiaoting, Mohammed Ismail, XIAO Li, JIANG Zhenzhou, ZHANG Luyong, SUN Lixin. Research progress of lncRNA regulating signal transduction pathway in liver diseases[J]. Journal of China Pharmaceutical University, 2020, 51(3): 277-286. DOI: 10.11665/j.issn.1000-5048.20200304
    [2]MEI Jiahao, HONG Ze, WANG Chen. Advances of drugs in targeting cGAS-STING signaling pathway[J]. Journal of China Pharmaceutical University, 2020, 51(3): 249-259. DOI: 10.11665/j.issn.1000-5048.20200301
    [3]LIU Zongliang, ZHANG Renmei, MENG Qingguo. Advances of targeting heat shock protein 70 drugs[J]. Journal of China Pharmaceutical University, 2017, 48(4): 416-424. DOI: 10.11665/j.issn.1000-5048.20170405
    [4]TAN Chengning, HUANG Jinghan, LI Chunhong, XIA Zhining, YANG Fengqing. Applications of proteomics in the study of cell signal pathways[J]. Journal of China Pharmaceutical University, 2017, 48(4): 384-395. DOI: 10.11665/j.issn.1000-5048.20170402
    [5]CHEN Ming, XIE Zhouling, LI Tinghan, WEI Zhihui, ZHAO Lu, LI Zhiyu. Advances in research on a novel antitumor target CDK9 and its inhibitors[J]. Journal of China Pharmaceutical University, 2017, 48(2): 233-241. DOI: 10.11665/j.issn.1000-5048.20170216
    [6]MEI Huifang, SUN Lixin, JIANG Zhenzhou, ZHANG Luyong. Sphingosine 1-phosphate signaling pathway:a novel target for regulation of epithelial and endothelial barrier function[J]. Journal of China Pharmaceutical University, 2016, 47(6): 654-660. DOI: 10.11665/j.issn.1000-5048.20160604
    [7]HUANG Shaoliang, ZHAO Li, GUO Qinglong, WU Yulin. Advances of Hedgehog pathway in tumor resistance[J]. Journal of China Pharmaceutical University, 2016, 47(3): 259-266. DOI: 10.11665/j.issn.1000-5048.20160302
    [8]ZHANG Jinghui, WANG Yajing, HU Rong. Roles of Moesin in tumor progression[J]. Journal of China Pharmaceutical University, 2015, 46(3): 371-375. DOI: 10.11665/j.issn.1000-5048.20150319
    [9]WANG Jing, ZHANG Hui-bin, ZHOU Jin-pei, LI Qing. Advances in new anti-tuberculosis targets and related drugs[J]. Journal of China Pharmaceutical University, 2012, 43(1): 1-8.
    [10]Gene Knockout Model and New Drug Target Discovery[J]. Journal of China Pharmaceutical University, 2004, (1): 3-8.

Catalog

    Get Citation
    PDF
    XML
    Article views (756) PDF downloads (2627) Cited by()
    Turn off MathJax
    Article Contents
    Abstract
    References
    Related Articles

    Copyright © Journal of China Pharmaceutical University苏ICP备12050101号-2

    Address：24 Tongjia Lane, Nanjing City, Jiangsu Province （210009）Tel: 025-83271566E-mail: xuebao@cpu.edu.cn

    Supported by: Beijing Renhe Information Technology Co., Ltd.  Baidu Analytics

    Total visits：415043

    /

    DownLoad:  Full-Size Img  PowerPoint
    Return
    Return